Indicative Announcement on "Chipscreen Convertible Bonds" Expected to Meet Conditions for Redemption
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Indicative Announcement on "Chipscreen Convertible Bonds" Expected to Meet Conditions for Redemption
Filed with SSE · · 4 pages · Chinese
Release
Shenzhen Chipscreen Biosciences Co. Ltd. on 6ix
Earlier from Shenzhen Chipscreen Biosciences
- Announcement on Estimated Amount of Daily Related Party Transactions in 2026
- Prospectus for Issuance of A-shares to Specific Objects in 2024 (Registration Draft)
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Clinical Trials of Chiauranib Capsules
- Announcement on Voluntary Disclosure of Approval of Chidamide for Market Release by the Pharmaceutical Administration Bureau, Macao SAR
- Announcement on Voluntary Disclosure of Acceptance of the Clinical Trial Application for Chiglitazar Sodium Sustained-release Tablets
Later from Shenzhen Chipscreen Biosciences
- Announcement on Earnings Preannouncement for 2025
- Announcement on Proposed Participation of Connected Persons in the Subscription of Shares Issued to Specific Objects and Related Party Transaction
- Announcement on the Thawing of Partially Frozen Shares Held by a Shareholder Owning 5% or More of the Company’s Equity
- Announcement on Execution of a License and Distribution Agreement with Nizhpharm
- Announcement on Signing Tripartite Supervision Agreement for Deposit of Raised Fund in Special Account
Follow Shenzhen Chipscreen Biosciences into a list and get an email when it puts out news.
Follow Shenzhen Chipscreen Biosciences